MX9606180A - Piridilbisfosfonatos para utilizarse como un agente terapeutico. - Google Patents
Piridilbisfosfonatos para utilizarse como un agente terapeutico.Info
- Publication number
- MX9606180A MX9606180A MX9606180A MX9606180A MX9606180A MX 9606180 A MX9606180 A MX 9606180A MX 9606180 A MX9606180 A MX 9606180A MX 9606180 A MX9606180 A MX 9606180A MX 9606180 A MX9606180 A MX 9606180A
- Authority
- MX
- Mexico
- Prior art keywords
- pyridylbisphosphonates
- therapeutical agent
- bone diseases
- pyridinylaminomethylidene
- tetralkyl
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invencion se relaciona con ciertos tetraalquilésteres del ácido piridinilaminometilidenobisfosfonico (I) sustituido opcionalmente en el anillo y su uso para el tratamiento de enfermedades oseas, tales como enfermedadesoseas osteolíticas debidas a malignidad, enfermedad de Paget y osteoporosis primaria y secundaria.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9402001-3 | 1994-06-09 | ||
PCT/FI1995/000315 WO1995033466A1 (en) | 1994-06-09 | 1995-06-02 | Pyridylbisphosphonates for use as a therapeutical agent |
Publications (2)
Publication Number | Publication Date |
---|---|
MXPA96006180A MXPA96006180A (es) | 1998-01-01 |
MX9606180A true MX9606180A (es) | 1998-01-31 |
Family
ID=39165258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9606180A MX9606180A (es) | 1995-06-02 | 1995-06-02 | Piridilbisfosfonatos para utilizarse como un agente terapeutico. |
Country Status (1)
Country | Link |
---|---|
MX (1) | MX9606180A (es) |
-
1995
- 1995-06-02 MX MX9606180A patent/MX9606180A/es active IP Right Grant
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0662075A4 (en) | PROSTAGLANDIN ANALOGUE FOR TREATING OSTEOPOROSIS. | |
BG100910A (en) | The use of bisphosphonates for the inhibition of osteal resorption after the implantation of orthopedic prosthesis | |
IL104109A (en) | Pharmaceutical compositions containing aldenorate for treating periodontal diseases | |
SE8704248D0 (sv) | Medical use | |
HU9603375D0 (en) | Pyridylbisphosphonates for use as a therapeutical agent | |
HRP950261B1 (en) | Wet granulation formulation for bisphosphonic acids | |
AU1022999A (en) | 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs | |
EP0341961A3 (en) | Polymalonic acids as boneaffinity agents | |
AU3530095A (en) | Prostagladin analogues by the oral or vaginal route for the routine management of the third stage of labour | |
IL134263A0 (en) | Use of phanquinone for the treatment of alzheimer's disease | |
MY103790A (en) | Novel compound for the treatment of several bone affecting diseases | |
SE8903529D0 (sv) | Medical use | |
SE9303853D0 (sv) | The use of an ester of inositoltrisphosphate for the preparing of medicaments | |
MX9606180A (es) | Piridilbisfosfonatos para utilizarse como un agente terapeutico. | |
CA2192456A1 (en) | Pyridylbisphosphonates for use as a therapeutical agent | |
GB9821671D0 (en) | Plant extracts for the treatment of increased bone resorption | |
AU7436098A (en) | Use of mizolastine for preparing a medicine for treating inflammation | |
IT1255218B (it) | Gamma-derivati del gamma-butirrolattone, processi per la loro preparazione e composizioni terapeutiche che li contengono per il trattamento di patologie con sintomatologia convulsiva ed ansiosa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
GB | Transfer or rights | ||
HC | Change of company name or juridical status | ||
HC | Change of company name or juridical status |